BRPI0716532A2 - compostos azabicÍclios como inidores de reabsorÇço de monoaminas - Google Patents

compostos azabicÍclios como inidores de reabsorÇço de monoaminas

Info

Publication number: BRPI0716532A2
Authority: BR; Brazil
Prior art keywords: resorption inhibitors; azabicyclic compounds; monoamine resorption; monoamine; azabicyclic
Prior art date: 2006-09-11

Application number

BRPI0716532-3A2A

Other languages

English (en)

Inventor

Barbara Bertani

Fabio Romano Di

Fabrizio Micheli

Giovanna Tedesco

Silvia Terreni

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-09-11

Filing date

2007-09-07

Publication date

2013-09-24

2006-09-11 Priority claimed from GB0617868A external-priority patent/GB0617868D0/en

2006-09-11 Priority claimed from GB0617863A external-priority patent/GB0617863D0/en

2007-08-22 Priority claimed from GB0716371A external-priority patent/GB0716371D0/en

2007-09-07 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2013-09-24 Publication of BRPI0716532A2 publication Critical patent/BRPI0716532A2/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Virology (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Obesity (AREA)
Anesthesiology (AREA)
AIDS & HIV (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Pregnancy & Childbirth (AREA)
Child & Adolescent Psychology (AREA)
Oncology (AREA)
Emergency Medicine (AREA)

BRPI0716532-3A2A 2006-09-11 2007-09-07 compostos azabicÍclios como inidores de reabsorÇço de monoaminas BRPI0716532A2 (pt)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0617868A GB0617868D0 (en)	2006-09-11	2006-09-11	Chemical compounds
GB0617863A GB0617863D0 (en)	2006-09-11	2006-09-11	Chemical compounds
GB0716371A GB0716371D0 (en)	2007-08-22	2007-08-22	Chemical compounds
PCT/EP2007/059381 WO2008031772A1 (en)	2006-09-11	2007-09-07	Azabicyclic compounds as inhibitors of monoamines reuptake

Publications (1)

Publication Number	Publication Date
BRPI0716532A2 true BRPI0716532A2 (pt)	2013-09-24

Family

ID=38561834

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0716532-3A2A BRPI0716532A2 (pt)	2006-09-11	2007-09-07	compostos azabicÍclios como inidores de reabsorÇço de monoaminas

Country Status (19)

Country	Link
US (2)	US20100035914A1 (pt)
EP (1)	EP2064186A1 (pt)
JP (1)	JP4448198B2 (pt)
KR (1)	KR20090064447A (pt)
AR (1)	AR062737A1 (pt)
AU (1)	AU2007296301A1 (pt)
BR (1)	BRPI0716532A2 (pt)
CA (1)	CA2662538A1 (pt)
CL (1)	CL2007002619A1 (pt)
CO (1)	CO6150149A2 (pt)
CR (1)	CR10671A (pt)
EA (1)	EA200970266A1 (pt)
IL (1)	IL197297A0 (pt)
MA (1)	MA30767B1 (pt)
MX (1)	MX2009002625A (pt)
NO (1)	NO20091099L (pt)
PE (1)	PE20081368A1 (pt)
TW (1)	TW200826934A (pt)
WO (1)	WO2008031772A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2662538A1 (en)	2006-09-11	2008-03-20	Glaxo Group Limited	Azabicyclic compounds as inhibitors of monoamines reuptake
GB0716573D0 (en) *	2007-08-24	2007-10-03	Glaxo Group Ltd	Chemical compounds
GB0804326D0 (en) *	2008-03-07	2008-04-16	Glaxo Group Ltd	Novel compounds
WO2010125033A1 (en) *	2009-04-29	2010-11-04	Glaxo Group Limited	Azabicyclo[4.1.0]heptane derivatives
WO2010130672A1 (en) *	2009-05-12	2010-11-18	Glaxo Group Limited	Azabicyclo [4.1.0] heptane derivatives and their use as monoamine reuptake inhibitors
WO2010133569A1 (en) *	2009-05-20	2010-11-25	Glaxo Group Limited	Azabicyclo[4.1.0]heptane derivatives
WO2010146025A1 (en) *	2009-06-17	2010-12-23	Glaxo Group Limited	Tricyclic azabicyclo [4.1.0] heptane derivatives as inhibitors of serotonin, dopamine and norepinephrine re-uptake
RU2571414C2 (ru)	2010-09-22	2015-12-20	Эйсай Ар Энд Ди Менеджмент Ко., Лтд.	Циклопропановые соединения
DE102011100831A1 (de)	2011-05-07	2012-11-08	Studiengesellschaft Kohle Mbh	Verfahren zur Herstellung von GSK 1360707 und verwandter Verbindungen mit 6-Aryl-1-[(alkyloxy) alkyl]-3-azabicyclo[4.1.0]heptan Grundgerüst
JP6659681B2 (ja)	2014-10-23	2020-03-04	エーザイ・アール・アンド・ディー・マネジメント株式会社	不眠症を治療するための組成物および方法
CA3188340A1 (en)	2020-08-13	2022-02-17	Boehringer Ingelheim International Gmbh	Treatment of cognitive impairement associated with schizophrenia
KR20230088761A (ko)	2020-10-13	2023-06-20	베링거 인겔하임 인터내셔날 게엠베하	재가공하는 방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2004A (en) *		1841-03-12		Improvement in the manner of constructing and propelling steam-vessels
US2008A (en) *		1841-03-18		Gas-lamp eok conducting gas pkom ah elevated buhner to one below it
US4131611A (en) *	1975-07-31	1978-12-26	American Cyanamid Company	Azabicyclohexanes
US4435419A (en) *	1981-07-01	1984-03-06	American Cyanamid Company	Method of treating depression using azabicyclohexanes
AU672644B2 (en)	1992-12-23	1996-10-10	Neurosearch A/S	Aryl substituted heterocyclic compounds
ZA971525B (en) *	1996-02-22	1997-10-21	Neurosearch As	Tropane derivatives, their preparation and use.
ES2329739T3 (es) *	1997-04-07	2009-11-30	Georgetown University	Analogos de cocaina.
US6303627B1 (en)	1998-06-19	2001-10-16	Eli Lilly And Company	Inhibitors of serotonin reuptake
US6372919B1 (en) *	2001-01-11	2002-04-16	Dov Pharmaceutical, Inc.	(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
US20060173064A1 (en)	2001-08-24	2006-08-03	Lippa Arnold S	(-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
US6569887B2 (en) *	2001-08-24	2003-05-27	Dov Pharmaceuticals Inc.	(−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US7223788B2 (en)	2003-02-14	2007-05-29	Sanofi-Aventis Deutschland Gmbh	Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
DE10306250A1 (de)	2003-02-14	2004-09-09	Aventis Pharma Deutschland Gmbh	Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP1735302B1 (en)	2004-02-27	2010-06-16	Eli Lilly And Company	4-amino-piperidine derivatives as monoamine uptake inhibitors
CA2662538A1 (en)	2006-09-11	2008-03-20	Glaxo Group Limited	Azabicyclic compounds as inhibitors of monoamines reuptake

2007
- 2007-09-07 CA CA002662538A patent/CA2662538A1/en not_active Abandoned
- 2007-09-07 WO PCT/EP2007/059381 patent/WO2008031772A1/en not_active Ceased
- 2007-09-07 EA EA200970266A patent/EA200970266A1/ru unknown
- 2007-09-07 US US12/440,852 patent/US20100035914A1/en not_active Abandoned
- 2007-09-07 KR KR1020097007365A patent/KR20090064447A/ko not_active Withdrawn
- 2007-09-07 AU AU2007296301A patent/AU2007296301A1/en not_active Abandoned
- 2007-09-07 MX MX2009002625A patent/MX2009002625A/es unknown
- 2007-09-07 BR BRPI0716532-3A2A patent/BRPI0716532A2/pt not_active IP Right Cessation
- 2007-09-07 JP JP2009527793A patent/JP4448198B2/ja not_active Expired - Fee Related
- 2007-09-07 EP EP07803326A patent/EP2064186A1/en not_active Withdrawn
- 2007-09-07 PE PE2007001202A patent/PE20081368A1/es not_active Application Discontinuation
- 2007-09-07 US US11/851,459 patent/US7691893B2/en not_active Expired - Fee Related
- 2007-09-10 TW TW096133638A patent/TW200826934A/zh unknown
- 2007-09-10 CL CL200702619A patent/CL2007002619A1/es unknown
- 2007-09-11 AR ARP070104006A patent/AR062737A1/es not_active Application Discontinuation
2009
- 2009-02-26 IL IL197297A patent/IL197297A0/en unknown
- 2009-03-10 CO CO09024346A patent/CO6150149A2/es unknown
- 2009-03-13 NO NO20091099A patent/NO20091099L/no not_active Application Discontinuation
- 2009-03-19 CR CR10671A patent/CR10671A/es not_active Application Discontinuation
- 2009-03-30 MA MA31737A patent/MA30767B1/fr unknown

Also Published As

Publication number	Publication date
CR10671A (es)	2009-04-29
WO2008031772A1 (en)	2008-03-20
MA30767B1 (fr)	2009-10-01
AU2007296301A1 (en)	2008-03-20
JP2010502761A (ja)	2010-01-28
US7691893B2 (en)	2010-04-06
TW200826934A (en)	2008-07-01
JP4448198B2 (ja)	2010-04-07
EA200970266A1 (ru)	2009-08-28
MX2009002625A (es)	2009-03-24
US20080114049A1 (en)	2008-05-15
NO20091099L (no)	2009-04-03
CO6150149A2 (es)	2010-04-20
AR062737A1 (es)	2008-11-26
US20100035914A1 (en)	2010-02-11
CL2007002619A1 (es)	2008-04-18
CA2662538A1 (en)	2008-03-20
KR20090064447A (ko)	2009-06-18
IL197297A0 (en)	2009-12-24
PE20081368A1 (es)	2008-11-19
EP2064186A1 (en)	2009-06-03

Legal Events

Date	Code	Title	Description
2014-08-26	B08L	Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]	Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 5A, 6A E 7A ANUIDADES.
2020-11-10	B08I	Publication cancelled [chapter 8.9 patent gazette]	Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2277 DE 26/08/2014 POR TER SIDO INDEVIDA.
2020-11-17	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A, 7A, 8A, 9A, 10A, 11A, 12A E 13A ANUIDADES.
2021-03-09	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
LTC2004635I2 (lt)	2021-05-25	Pakeistieji enaminokarbonilo junginiai
BRPI0814426A2 (pt)	2015-01-06	Compostos heterocíclicos úteis como inibidores de mk2
BRPI0814432A2 (pt)	2017-05-09	pirimidinadiaminas substituídas por amina cíclica como inibidores de pkc
CR10831A (es)	2009-06-18	INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA
BRPI0811639A2 (pt)	2014-09-30	Cicloaquilaminas fenil substituídas como inibidores da recaptação de monoamina
BRPI0814797A2 (pt)	2015-02-03	Inibidores dna-pk
BRPI0812825A2 (pt)	2014-12-09	Derivados ftalazinona como inibidores de parp-1
BRPI0921860A2 (pt)	2015-12-29	compostos de benzonaftiridina como inibidores de autotaxina
BRPI0719499A2 (pt)	2015-06-16	Composições de poliolefina
EP2046887A4 (en)	2010-03-31	Light-Crosslinkable Polyolefin Compositions
BRPI0920135A2 (pt)	2019-09-24	imidazopiridazinacarbonitrilos úteis como inibidores de quinase
BRPI0811176A2 (pt)	2014-10-29	Ferramenta de nível com fixação
BRPI0912786A2 (pt)	2017-05-23	método eficaz de referenciamento de localização
BRPI0815042A2 (pt)	2015-02-10	Compostos de pirazol
EP2089308A4 (en)	2014-08-06	DONOR
EP2305306A4 (en)	2012-08-29	NEURO INVASION INHIBITOR
BRPI0718874A2 (pt)	2015-06-23	Compostos orgânicos
BRPI0717460A2 (pt)	2013-12-24	Composições de inibidores de chk1
NO20084803L (no)	2008-11-19	organiske forbindelser
BRPI0718478A2 (pt)	2013-11-26	Compostos orgânicos
BRPI0810365A2 (pt)	2014-10-29	Inibidores de mlc-1 de indol 7-substituído
EP2171621A4 (en)	2012-05-30	INQUIRY STATISTICS PROVIDER
ATE524477T1 (de)	2011-09-15	Aziridinylepothilonverbindungen
BRPI0919818A2 (pt)	2019-09-24	inibidores de seprase seletivos
BRPI0712902A2 (pt)	2018-10-30	compostos orgânicos